ArticleComputational and structural biotechnology journal2026
Prediction of DNA N4-Methylcytosine Sites Based on a Position-Aligned Multi-branch Fusion Network.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While DNA N4-methylcytosine (4mC) plays regulatory roles in various organisms, its endogenous presence in mammalian genomes remains debated. Accurate identification of putative 4mC sites in eukaryotic genomes is impeded by scarce validated data and complex sequence dependencies. Although the mouse is a vital mammalian model for epigenetic studies, computational predictors capable of reliably screening murine 4mC candidate sites remain lacking. To address this, we propose TriAlignNet-4mC, a position-aligned triple-branch neural network designed for the precise and interpretable prediction of benchmark mouse 4mC candidate sites. Our framework unifies local biochemical properties, long-range contextual dependencies, and duplex-connectivity relations by integrating physicochemical descriptors, DNABERT embeddings, and duplex-connectivity-aware relational graph representations. Via position-aware alignment and late fusion, TriAlignNet-4mC generates comprehensive feature representations that markedly enhance prediction stability. Extensive benchmarking on a
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.